Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated in the trial, and none of…
Category:
Stock
Today on Fox Business Varney & Company, David Bahnsen (The Bahnsen Group) was asked if the current market reminded him of the Dot.com Bubble. He said it did, but not…
While the S&P 500 continues to move higher, the number of stocks participating to the upside continues to decline. In other words, market breadth is deteriorating. However, it has been…
Note to the reader: This is the twenty-fifth and final in a series of articles I’m publishing here, taken from my book, “Investing with the Trend.” Hopefully, you will find…
The Dow Jones Industrial Average ($INDU) may not be the comprehensive measure of the US economy it once was in the early 20th century. However, if you’re holding (or looking…
In this edition of StockCharts TV‘s The Final Bar, Dave celebrates Nvidia’s rise to overtake Microsoft (MSFT) as the largest company by market cap, creating chaos in the Technology Sector ETF (XLK)…
In this video from StockCharts TV, Julius shares a rare RRG rotational pattern that he’s never seen before! He then follows up with a breakdown of the current sector rotation…
We’re heading deeper into the summer months, which usually means higher demand for energy products, namely crude oil and gas. While demand tends to be seasonal, the entire crude complex…
In this edition of StockCharts TV‘s The Final Bar, Dave breaks down an upside follow-through day for the S&P 500 and Nasdaq, and highlights the continued weakness in market breadth indicators. Dave…
In early 2024, gold reached the price objective derived from the breakout of the large triangle that had evolved beginning in early 2022. Upon reaching the area of the objective,…